Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-30

Clinical Trial Update: Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting safety and efficacy results for peginesatide as maintenance therapy for anemia in adults with chronic kidney disease on hemodialy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peginesatide (peginesatide)

Snippet

Sponsor: Affymax | Conditions: Chronic Renal Failure, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-07-30